Search results
Here's What AstraZeneca's Recent FDA News Means for Shareholders
Motley Fool· 2 years agoOn April 25, AstraZeneca's (NASDAQ: AZN) biologics license application for its tremelimumab and...
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Motley Fool· 1 year agoBritish drugmaker AstraZeneca (NASDAQ: AZN) and U.S.-based Ionis Pharmaceuticals (NASDAQ: IONS) have...
The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100
Motley Fool· 6 months agoIt's probably safe to assume that you've seen a commercial or heard a catchy jingle for any (if not...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 8 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Dow Jones Futures Fall As Market Retreat Gains Steam; Elon Musk Makes This FSD Move
Investor's Business Daily· 2 years agoDow Jones futures fell sharply Monday morning, along with S&P 500 futures and Nasdaq futures, with...
Could This New Drug Launch Be a Hit for Viatris?
Motley Fool· 1 year agoLast December, Viatris (NASDAQ: VTRS) and Kindeva Drug Delivery lost in court against AstraZeneca (NASDAQ: AZN) over a patent dispute regarding one of...
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
Motley Fool· 2 years agoBig pharmas like AstraZeneca (NASDAQ: AZN) rise and fall based on how much money they can earn from their medicines on the market. With regulators at the European Medicines Agency (EMA) now ...
Dow Jones Futures Rise As Key Economic Signal Rebounds; Tesla Rivals In Buy Zones
Investor's Business Daily· 2 years agoDow Jones futures rose modestly Thursday morning, along with S&P 500 futures and Nasdaq futures. The...
2 Best Biotech Stocks to Buy Right Now
Motley Fool· 11 months agoWhen done right, investing in pharmaceutical companies can be a lucrative endeavor. This is because as long as there are diseases and infections,...
